Pituitary Flashcards
GH MOA
Physiologic effects are exerted either directly or mediated through somatomedins (Insulin-like growth factors-IGF-1 and IGF-2)
In acromegaly, IGF-1 levels are consistently high, reflecting elevated GH
Therapeutic uses of GH
Congenital/acquired GH deficiency (Dwarfism)
Prader-Willi syndrome
GH deficiency in adults
AIDS related muscle wasting and cachexia
Turner syndrome (to stimulate growth)
Idiopathic short stature (in children)
also approved for treatment of patients with short bowel syndrome (with glutamine)
used by athletes for a purported increase in muscle mass and athletic performance- one of the drugs banned by the Olympic Committee
FDA also approved in 1993 the use of recombinant bovine Growth Hormone (rbGH) in dairy cattle to increase milk production
GH ADR in children
Increased Intracranial tension Papilledema Headache Hypothyroidism*** Scoliosis DM
GH ADR in adults
Peripheral edema Arthralgia Myalgia Carpal tunnel syndrome DM
GH contraindication
Obese patients
Patients with closed epiphyses who do not have GH deficiency
Patients with a known malignancy
Mecasermin
recombinant human (rh) IGF-1
Mecasermin approved for the treatment of patients with?
GH deficiency with antibodies against GH
severe IGF-1 deficiency that is not responsive to GH
mutations in the GH receptor
primary IGF-1 deficiency
Most common ADR of mecasermin
hypoglycemia
take food 20 min before or after administration of the drug
Octerotide
a synthetic octapeptide analog of somatostatin
more potency and longer half-life than the natural compound (Somatostatin)
Octerotide used in?
treatment of acromegaly and gigantism caused by hormone-secreting tumors, pituitary tumors that secrete thyroid stimulating hormone (thyrotropinoma)
hypersecretory diarrheas associated with tumors producing the vasoactive intestinal peptide (VIPomas), Carcionoid syndrome
useful in acute variceal bleeding
Lanreotide
Long acting octreotide
ADR of somatostatin analogs
Gi problems
Gall stones
Vit B12 deficiency on long term use
Pegvisomant
GH receptor antagonist [recombinant polyethylene glycol (PEG) variant GH (mutant GH)]
acts as an antagonist at GH receptors
Pegvisomant used in?
treatment of acromegaly that is refractory to other modes of surgical, radiologic, or pharmacologic intervention
Gonadorelin
Short acting GnRH analog
Gonadorelin uses
“Pulsatile”manner to stimulate pituitary to secrete FSH and LH; (however, continuous administration inhibits FSH and LH release)
Diagnostic purpose (hypogonadism)
Female infertility: to induce ovulation and treat infertility in women with Hypothalamic amenorrhea
Male infertility
Goserelin, Nadarelin, Leuprolide, Histrelin, Triptorelin
Long acting Synthetic GnRH analogue
After initial stimulation, they will cause suppression of gonadotropin (FSH, LH) release.
Uses of long acting GnRH
Precocious puberty Breast Ca Prostate Ca Uterine leiomyomata (uterine fibroids) Endometriosis
AdR of GnRH analogue
gonadorelin: hypersensitivity, dermatitis and headache
In women, the analogs may cause:
hot flushes and sweating
diminished libido, depression and ovarian cysts
Ganirelix, Cetrorelix, Abarelix, Degarelix
competitive antagonists at GnRH receptors
inhibit the secretion of FSH and LH in a dose-dependent manner
do not cause surge of testosterone or estradiol upon initiation of therapy
approved for preventing the LH surge during controlled ovarian stimulation (for the purpose of assisted reproductive technologies such IVF)
given SC or IM
Menotropins
Gonadotropin prep:
(human menopausal gonadotropins, hMG) (LH + FSH)- obtained from the urine of menopausal women
.Largely being replaced by recombinant Gonadotropins
hCG
gonadotropin prep:
Human chorionic gonadotropin) - a placental hormone, has LH like activity
- also excreted in urine and acts as an LH agonist
Urofollitropin
FSH obtained from menopausal women and is devoid of LH activity
Follitropin
human FSH manufactured by recombinant DNA technology